Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Prezcobix (darunavir/cobicistat) and Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) are both antiretroviral medications used to treat HIV infections, but they have some key differences. Prezcobix combines a protease inhibitor (darunavir) and a booster (cobicistat), while Genvoya includes an integrase strand transfer inhibitor (elvitegravir), two nucleoside reverse transcriptase inhibitors (emtricitabine and tenofovir alafenamide), and a booster (cobicistat). Prezcobix is typically taken with other HIV medications, whereas Genvoya is a complete regimen on its own. Both medications are available only as a brand-name medication. Both medications need to be taken with food and are taken once daily. However, Genvoya has the risk of worsening hepatitis B if the medication is stopped suddenly. Prezcobix, on the other hand, has specific interactions with other medications and must be used carefully in people with sulfa allergies.
Prezcobix (darunavir / cobicistat)
Genvoya
Prezcobix (darunavir / cobicistat)
Genvoya
Summary of Prezcobix vs. Genvoya
Summary for HIV ARV
Prescription only
Prezcobix (darunavir / cobicistat), also known as DRV/COBI, is an antiretroviral (ARV) medication that treats HIV (human immunodeficiency virus) infections in people who weigh at least 88 pounds. It's typically taken with other HIV ARVs to make up a complete treatment regimen. Prezcobix (darunavir / cobicistat) is an oral tablet that's taken once daily. It's important to take the medication every day to prevent HIV drug resistance (when HIV medications no longer work). A side effect of Prezcobix (darunavir / cobicistat) is a skin rash that appears within the first month of treatment, but it typically goes away on its own.